Tech Company Financing Transactions

Aldagen Funding Round

Harbert Venture Partners, Intersouth Partners and Aurora Funds participated in a $17.3 million Series C funding round for Aldagen. The financing round closed on 12/19/2006.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

Biopharmaceutical

Mailing Address

2810 Meridian Pkwy. 148
Durham, NC 27713
USA

Phone

(919) 484-2571

Website

www.aldagen.com

Email Address

[email protected]

Overview

Aldagen is a clinical-stage regenerative medicine company developingand commercializing products to treat vascular and degenerative diseases.The company's proprietary products can identify and isolate potent, highlyeffective adult stem and progenitor cells which can be quickly administeredto regenerate or repair tissue.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Lyle Hohnke

        

Chief Medical Officer

James Hinson

        

Chief Operating Officer

Edward Field

        

Browse more venture capital transactions:

Prev: 12/19/2006: Double Fusion venture capital transaction
Next: 12/20/2006: WaterHealth International venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on funding rounds that are announced publicly. All VC database entries reported here come from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary